Литература Aalkjaer C, Mulvany mj, Nyborg nc. Atrial natriuretic factor causes specific relaxation of rat renal arcuate arteries



Yüklə 192,52 Kb.
səhifə3/4
tarix24.12.2017
ölçüsü192,52 Kb.
#17776
növüЛитература
1   2   3   4
Физиологический журнал СССР. 1990;76(7):875-880.

  • Nakajima K, Onishi K, Dohi K, Tanabe M, Kurita T, Yamanaka T, Ito M, Isaka N, Nobori T, Nakano T. Effects of human atrial natriuretic peptide on cardiac function and hemodynamics in patients with high plasma BNP levels. Int J Cardiol. 2005;104(3):332-337. doi: 10.1016/j.ijcard.2004.12.020

  • Nakamaru M, Inagami T. Atrial natriuretic factor inhibits norepinephrine release evoked by sympathetic nerve stimulation in isolated perfused rat mesenteric arteries. Eur J Pharmacol. 1986;123(3):459-461.

  • Nakamura M, Arakawa N, Yoshida H, Makita S, Hiramori K. Vasodilatory effects of C-type natriuretic peptide on forearm resistance vessels are distinct from those of atrial natriuretic peptide in chronic heart failure. Circulation. 1994;90(3):1210-1214.

  • Nakao K, Yamada T, Itoh H, Shirakami G, Saito Y, Sugawara A, Mukoyama M, Arai H, Hosoda K, Morii N. Possible antagonistic relationship between atrial natriuretic peptide (ANP)-brain natriuretic peptide (BNP) system and brain renin-angiotensin system in central control of body fluid and cardiovascular function. Clin Exp Hypertens A. 1988;10(6):1289-1291.

  • Nakayama K. Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins. Biochem J. 1997;327(Pt 3):625-635.

  • Nazario B, Hu RM, Pedram A, Prins B, Levin ER. Atrial and brain natriuretic peptides stimulate the production and secretion of C-type natriuretic peptide from bovine aortic endothelial cells. J Clin Invest. 1995;95(3):1151-1157. doi: 10.1172/JCI117763

  • Neeland IJ, Winders BR, Ayers CR, Das SR, Chang AY, Berry JD, Khera A, McGuire DK, Vega GL, de Lemos JA, Turer AT. Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile. J Am Coll Cardiol. 2013;62(8):752-760. doi: 10.1016/j.jacc.2013.03.038

  • Newton-Cheh C, Johnson T, Gateva V, Tobin MD, Bochud M, Coin L, Najjar SS, Zhao JH, Heath SC, Eyheramendy S, Papadakis K, Voight BF, Scott LJ, Zhang F, Farrall M, Tanaka T, Wallace C, Chambers JC, Khaw KT, Nilsson P, van der Harst P, Polidoro S, Grobbee DE, Onland-Moret NC, Bots ML, et al. Genome-wide association study identifies eight loci associated with blood pressure. Nat Genet. 2009;41(6):666-676. doi: 10.1038/ng.361

  • Neyses L, Nitsch J, Biegel T, Heinrichs S, Nissen HD, Lüderitz B. Elevated levels of atrial natriuretic peptide and plasma catecholamines in arterial hypertension—indications for an interaction. Z Kardiol. 1988;77(7):407-412.

  • Nguyen TT, Ong H, De Léan A. Secretion and biosynthesis of atrial natriuretic factor by cultured adrenal chromaffin cells. FEBS Lett. 1988;231(2):393-396.

  • Nir A, Zhang DF, Fixler R, Burnett JC, Eilam Y, Hasin Y. C-type natriuretic peptide has a negative inotropic effect on cardiac myocytes. Eur J Pharmacol. 2001;412(3):195-201.

  • Nonoguchi H, Knepper MA, Manganiello VC. Effects of atrial natriuretic factor on cyclic guanosine monophosphate and cyclic adenosine monophosphate accumulation in microdissected nephron segments from rats. J Clin Invest. 1987;79(2):500-507. doi: 10.1172/JCI112840

  • Nonoguchi H, Sands JM, Knepper MA. ANF inhibits NaCl and fluid absorption in cortical collecting duct of rat kidney. Am J Physiol. 1989;256(1 Pt 2):F179-F186.

  • Nonoguchi H, Izumi Y, Nakayama Y, Matsuzaki T, Yasuoka Y, Inoue T, Inoue H, Mouri T, Kawahara K, Saito H, Tomita K. Effects of atrial natriuretic peptide on bicarbonate transport in long- and short-looped medullary thick ascending limbs of rats. PLoS One. 2013;8(12):e83146. doi: 10.1371/journal.pone.0083146

  • Ogawa Y, Itoh H, Tamura N, Suga S, Yoshimasa T, Uehira M, Matsuda S, Shiono S, Nishimoto H, Nakao K. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene. J Clin Invest. 1994;93(5):1911-1921. doi: 10.1172/JCI117182

  • Ogawa T, Linz W, Stevenson M, Bruneau BG, Kuroski de Bold ML, Chen JH, Eid H, Schölkens BA, de Bold AJ. Evidence for load-dependent and load-independent determinants of cardiac natriuretic peptide production. Circulation. 1996;93(11):2059-2067.

  • Ogawa T, de Bold AJ. The heart as an endocrine organ. Endocr Connect. 2014;3(2):R31-R44. doi: 10.1530/EC-14-0012

  • Ohte N, Cheng CP, Suzuki M, Little WC. Effects of atrial natriuretic peptide on left ventricular performance in conscious dogs before and after pacing-induced heart failure. J Pharmacol Exp Ther. 1999;291(2):589-595.

  • Okamura T, Inoue S, Toda N. Action of atrial natriuretic peptide (ANP) on dog cerebral arteries: evidence that neurogenic relaxation is not mediated by release of ANP. Br J Pharmacol. 1989;97(4):1258-1264.

  • Okumura K, Yasue H, Fujii H, Kugiyama K, Matsuyama K, Yoshimura M, Jougasaki M, Kikuta K, Kato H, Tanaka H, et al. Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables. J Am Coll Cardiol. 1995;25(2):342-348.

  • Ong H, Lazure C, Nguyen TT, McNicoll N, Seidah N, Chrétien M, De Léan A. Bovine adrenal chromaffin granules are a site of synthesis of atrial natriuretic factor. Biochem Biophys Res Commun. 1987;147(3):957-963.

  • Oparil S, Chen YF, Peng N, Wyss JM. Anterior hypothalamic norepinephrine, atrial natriuretic peptide, and hypertension. Front Neuroendocrinol. 1996;17(2):212-246. doi: 10.1006/frne.1996.0006

  • Ou LC, Sardella GL, Hill NS, Thron CD. Does atrial natriuretic factor protect against right ventricular overload? I. Hemodynamic study. J Appl Physiol. 1989;67(4):1606-1611.

  • Ozawa T, Shinke T, Shite J, Takaoka H, Inoue N, Matsumoto H, Watanabe S, Yoshikawa R, Otake H, Matsumoto D, Ogasawara D, Yokoyama M, Hirata KI. Effects of human atrial natriuretic peptide on myocardial performance and energetics in heart failure due to previous myocardial infarction. J Cardiol. 2015;66(3):232-238. doi: 10.1016/j.jjcc.2014.12.020

  • Packer M, McMurray JJ, Desai AS, Gong J, Lefkowitz MP, Rizkala AR, Rouleau JL, Shi VC, Solomon SD, Swedberg K, Zile M, Andersen K, Arango JL, Arnold JM, Bělohlávek J, Böhm M, Boytsov S, Burgess LJ, Cabrera W, Calvo C, Chen CH, Dukat A, Duarte YC, Erglis A, Fu M, Gomez E, Gonzàlez-Medina A, Hagège AA, Huang J, Katova T, Kiatchoosakun S, Kim KS, Kozan Ö, Llamas EB, Martinez F, Merkely B, Mendoza I, Mosterd A, Negrusz-Kawecka M, Peuhkurinen K, Ramires FJ, Refsgaard J, Rosenthal A, Senni M, Sibulo AS Jr, Silva-Cardoso J, Squire IB, Starling RC, Teerlink JR, Vanhaecke J, Vinereanu D, Wong RC, PARADIGM-HF Investigators and Coordinators. Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure. Circulation. 2015;131(1):54-61. doi: 10.1161/CIRCULATIONAHA.114.013748

  • Palmer SC, Prickett TC, Espiner EA, Yandle TG, Richards AM. Regional release and clearance of C-type natriuretic peptides in the human circulation and relation to cardiac function. Hypertension. 2009;54(3):612-618. doi: 10.1161/HYPERTENSIONAHA.109.135608

  • Pandey KN. Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca (2+) release, and activation of protein kinase C. Front Mol Neurosci. 2014;7:75.eCollection. doi: 10.3389/fnmol.2014.00075

  • Park BM, Oh YB, Gao S, Cha SA, Kang KP, Kim SH. Angiotensin III stimulates high stretch-induced ANP secretion via angiotensin type 2 receptor. Peptides. 2013;42:131-137. doi: 10.1016/j.peptides.2013.01.018

  • Patel MB, Hintze TH. Atriopeptin 24 regulates myocardial function via Frank-Starling mechanism in conscious dogs. Am J Physiol. 1990;258(1 Pt 2): H183-H190.

  • Peake NJ, Hobbs AJ, Pingguan-Murphy B, Salter DM, Berenbaum F, Chowdhury TT. Role of C-type natriuretic peptide signalling in maintaining cartilage and bone function. Osteoarthritis Cartilage. 2014;22(11):1800-1807. doi: 10.1016/j.joca.2014.07.018

  • Perera RK, Sprenger JU, Steinbrecher JH, Hübscher D, Lehnart SE, Abesser M, Schuh K, El-Armouche A, Nikolaev VO. Microdomain switch of cGMP-regulated phosphodiesterases leads to ANP-induced augmentation of β-adrenoceptor-stimulated contractility in early cardiac hypertrophy. Circ Res. 2015;116(8):1304-1311. doi: 10.1161/CIRCRESAHA.116.306082

  • Pettersson A, Hedner J, Hedner T. Relationship between renal sympathetic activity and diuretic effects of atrial natriuretic peptide (ANP) in the rat. Acta Physiol Scand. 1989;135(3):323-333. doi: 10.1111/j.1748-1716.1989.tb08584.x

  • Pierkes M, Gambaryan S, Bokník P, Lohmann SM, Schmitz W, Potthast R, Holtwick R, Kuhn M. Increased effects of C-type natriuretic peptide on cardiac ventricular contractility and relaxation in guanylyl cyclase A-deficient mice. Cardiovasc Res. 2002;53(4):852-861.

  • Plante E, Menaouar A, Danalache BA, Broderick TL, Jankowski M, Gutkowska J. Treatment with brain natriuretic peptide prevents the development of cardiac dysfunction in obese diabetic db/db mice. Diabetologia. 2014;57(6):1257-1267. doi: 10.1007/s00125-014-3201-4

  • Porzionato A, Macchi V, Rucinski M, Malendowicz LK, De Caro R. Natriuretic peptides in the regulation of the hypothalamic-pituitary-adrenal axis. Int Rev Cell Mol Biol. 2010;280:1-39. doi: 10.1016/S1937-6448(10)80001-2

  • Potter LR. Natriuretic peptide metabolism, clearance and degradation. FEBS J. 2011;278(11):1808-1817. doi: 10.1111/j.1742-4658.2011.08082.x

  • Protter AA, Wallace AM, Ferraris VA, Weishaar RE. Relaxant effect of human brain natriuretic peptide on human artery and vein tissue. Am J Hypertens. 1996;9(5):432-436.

  • Rademaker MT, Charles CJ, Espiner EA, Frampton CM, Nicholls MG, Richards AM. Combined inhibition of angiotensin II and endothelin suppresses the brain natriuretic peptide response to developing heart failure. Clin Sci. 2004;106(6):569-576. doi: 10.1042/CS20030366

  • Rademaker MT, Richards AM. Cardiac natriuretic peptides for cardiac health. Clin Sci. 2005;108(1):23-36. doi: 10.1042/CS20040253

  • Rankin AJ, Swift FV. The inotropic effect of atrial natriuretic factor in the anesthetized rabbit. Pflugers Arch. 1990;417(4):353-359.

  • Re R. The myocardial intracellular renin-angiotensin system. Am J Cardiol. 1987;59(2):56A-58A.

  • Richards AM. The renin-angiotensin-aldosterone system and the cardiac natriuretic peptides. Heart. 1996;76(3 Suppl. 3):36-44.

  • Richards AM. C-type natriuretic peptide and cardiac fibrosis. Hypertension. 2011;57(2):154-155. doi: 10.1161/HYPERTENSIONAHA.110.163865

  • Rocha AS, Kudo LH. Atrial peptide and cGMP effects on NaCl transport in inner medullary collecting duct. Am J Physiol. 1990;259(2 Pt 2):F258-F268.

  • Rodseth RN, Biccard BM, Le Manach Y, Sessler DI, Lurati Buse GA, Thabane L, Schutt RC, Bolliger D, Cagini L, Cardinale D, Chong CP, Chu R, Cnotliwy M, Di Somma S, Fahrner R, Lim WK, Mahla E, Manikandan R, Puma F, Pyun WB, Radović M, Rajagopalan S, Suttie S, Vanniyasingam T, van Gaal WJ, Waliszek M, Devereaux PJ. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis. J Am Coll Cardiol. 2014;63(2):170-180. doi: 10.1016/j.jacc.2013.08.1630

  • Romano L, Coviello A, Jerez S, Peral de Bruno M. Role of nitric oxide on the vasorelaxant effect of atrial natriuretic peptide on rabbit aorta basal tone. Can J Physiol Pharmacol. 2002;80(10):1022-1029.

  • Romieu P, Gobaille S, Aunis D, Zwiller J. Injection of the neuropeptide CNP into dopaminergic rat brain areas decreases alcohol intake. Ann NY Acad Sci. 2008;1139:27-33. doi: 10.1196/annals.1432.050

  • Ropero AB, Soriano S, Tudurí E, Marroquí L, Téllez N, Gassner B, Juan-Picó P, Montanya E, Quesada I, Kuhn M, Nadal A. The atrial natriuretic peptide and guanylyl cyclase-A system modulates pancreatic beta-cell function. Endocrinology. 2010;151(8):3665-3674. doi: 10.1210/en.2010-0119

  • Rose RA, Anand-Srivastava MB, Giles WR, Bains JS. C-type natriuretic peptide inhibits L-type Ca2+ current in rat magnocellular neurosecretory cells by activating the NPR-C receptor. J Neurophysiol. 2005;94(1):612-621. doi: 10.1152/jn.00057.2005

  • Rose RA, Giles WR. Natriuretic peptide C receptor signalling in the heart and vasculature. J Physiol. 2008;586(2):353-366. doi: 10.1113/jphysiol.2007.144253

  • Ruskoaho H, Leskinen H, Magga J, Taskinen P, Mäntymaa P, Vuolteenaho O, Leppäluoto J. Mechanisms of mechanical load-induced atrial natriuretic peptide secretion: role of endothelin, nitric oxide, and angiotensin II. J Mol Med (Berl). 1997;75(11-12):876-885.

  • Sabrane K, Gambaryan S, Brandes RP, Holtwick R, Voss M, Kuhn M. Increased sensitivity to endothelial nitric oxide (NO) contributes to arterial normotension in mice with vascular smooth muscle-selective deletion of the atrial natriuretic peptide (ANP) receptor. J Biol Chem. 2003;278(20):17963-17968. doi: 10.1074/jbc.M213113200

  • Sabrane K, Kruse MN, Fabritz L, Zetsche B, Mitko D, Skryabin BV, Zwiener M, Baba HA, Yanagisawa M, Kuhn M. Vascular endothelium is critically involved in the hypotensive and hypovolemic actions of atrial natriuretic peptide. J Clin Invest. 2005;115(6):1666-1674. doi: 10.1172/JCI23360

  • Sagnella GA, Markandu ND, Shore AC, MacGregor GA. Plasma immunoreactive atrial natriuretic peptide and changes in dietary sodium intake in man. Life Sci. 1987;40(2):139-143.

  • Sagnella GA. Measurement and significance of circulating natriuretic peptides in cardiovascular disease. Clin Sci (Lond). 1998;95(5):519-529.

  • Salazar FJ, Fiksen-Olsen MJ, Opgenorth TJ, Granger JP, Burnett JC, Romero JC. Renal effects of ANP without changes in glomerular filtration rate and blood pressure. Am J Physiol. 1986;251(3 Pt 2):F532-F536.

  • Sangaralingham SJ, Heublein DM, Grande JP, Cataliotti A, Rule AD, McKie PM, Martin FL, Burnett JC. Urinary C-type natriuretic peptide excretion: a potential novel biomarker for renal fibrosis during aging. Am J Physiol Renal Physiol. 2011;301(5):F943-F952. doi: 10.1152/ajprenal.00170.2011

  • Sangaralingham SJ, Huntley BK, Martin FL, McKie PM, Bellavia D, Ichiki T, Harders GE, Chen HH, Burnett JC. The aging heart, myocardial fibrosis, and its relationship to circulating C-type natriuretic Peptide. Hypertension. 2011;57(2):201-207. doi: 10.1161/HYPERTENSIONAHA.110.160796

  • Sangaralingham SJ, McKie PM, Ichiki T, Scott CG, Heublein DM, Chen HH, Bailey KR, Redfield MM, Rodeheffer RJ, Burnett JC. Circulating C-type natriuretic peptide and its relationship to cardiovascular disease in the general population. Hypertension. 2015;65(6):1187-1194. doi: 10.1161/HYPERTENSIONAHA.115.05366

  • Savoie P, de Champlain J, Anand-Srivastava MB. C-type natriuretic peptide and brain natriuretic peptide inhibit adenylyl cyclase activity: interaction with ANF-R2/ANP-C receptors. FEBS Lett. 1995;370(1-2):6-10.

  • Scallan JP, Davis MJ, Huxley VH. Permeability and contractile responses of collecting lymphatic vessels elicited by atrial and brain natriuretic peptides. J Physiol. 2013;591(Pt 20):5071-5081. doi: 10.1113/jphysiol.2013.260042

  • Schiebinger RJ, Kem DC, Brown RD. Effect of atrial natriuretic peptide on ACTH, dibutyryl cAMP, angiotensin II and potassium-stimulated aldosterone secretion by rat adrenal glomerulosa cells. Life Sci. 1988;42(8):919-926.

  • Schirger JA, Heublein DM, Chen HH, Lisy O, Jougasaki M, Wennberg PW, Burnett JC. Presence of Dendroaspis natriuretic peptide-like immunoreactivity in human plasma and its increase during human heart failure. Mayo Clin Proc. 1999;74(2):126-130. doi: 10.4065/74.2.126

  • Schmidt H, Stonkute A, Jüttner R, Koesling D, Friebe A, Rathjen FG. C-type natriuretic peptide (CNP) is a bifurcation factor for sensory neurons. Proc Natl Acad Sci USA. 2009;106(39):16847-16852. doi: 10.1073/pnas.0906571106

  • Schmitt M, Broadley AJ, Nightingale AK, Payne N, Gunaruwan P, Taylor J, Lee L, Cockcroft J, Struthers AD, Frenneaux MP. Atrial natriuretic peptide regulates regional vascular volume and venous tone in humans. Arterioscler Thromb Vasc Biol. 2003;23(10):1833-1838. doi: 10.1161/01.ATV.0000084826.86349.1D

  • Schreier B, Börner S, Völker K, Gambaryan S, Schäfer SC, Kuhlencordt P, Gassner B, Kuhn M. The heart communicates with the endothelium through the guanylyl cyclase-A receptor: acute handling of intravascular volume in response to volume expansion. Endocrinology. 2008;149(8):4193-4199. doi: 10.1210/en.2008-0212

  • Schultz HD, Gardner DG, Deschepper CF, Coleridge HM, Coleridge JC. Vagal C-fiber blockade abolishes sympathetic inhibition by atrial natriuretic factor. Am J Physiol. 1988;255(1 Pt 2):R6-R13.

  • Schultz HD, Steele MK, Gardner DG. Central administration of atrial peptide decreases sympathetic outflow in rats. Am J Physiol. 1990;258(5 Pt 2):R1250-R1256.

  • Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG. Isolation and structural analysis of «urodilatin», a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr. 1988;66(17):752-759.

  • Schweitz H, Vigne P, Moinier D, Frelin C, Lazdunski M. A new member of the natriuretic peptide family is present in the venom of the green mamba (Dendroaspis angusticeps). J Biol Chem. 1992;267(20):13928-13932.

  • Scotland RS, Cohen M, Foster P, Lovell M, Mathur A, Ahluwalia A, Hobbs AJ. C-type natriuretic peptide inhibits leukocyte recruitment and platelet-leukocyte interactions via suppression of P-selectin expression. Proc Natl Acad Sci USA. 2005;102(40):14452-14457. doi: 10.1073/pnas.0504961102

  • Seguchi H, Nishimura J, Toyofuku K, Kobayashi S, Kumazawa J, Kanaide H. The mechanism of relaxation induced by atrial natriuretic peptide in the porcine renal artery. Br J Pharmacol. 1996;118(2):343-351.

  • Sexton PM, Zhuo J, Mendelsohn FA. Localization and regulation of renal receptors for angiotensin II and atrial natriuretic peptide. Tohoku J Exp Med. 1992;166(1):41-56.

  • Seymour AA, Sweet CS, Stabilito II, Emmert SE. Cardiac and hemodynamic esponses to synthetic atrial natriuretic factor in rats. Life Sci. 1987;40(6):511-519.

  • Shah SJ, Michaels AD. Acute effects of intravenous nesiritide on cardiac contractility in heart failure. J Card Fail. 2010;16(9):720-727. doi: 10.1016/j.cardfail.2010.04.008

  • Sharma RK, Duda T. Membrane guanylate cyclase, a multimodal transduction machine: history, present, and future directions. Front Mol Neurosci. 2014;7:56. doi: 10.3389/fnmol.2014.00056

  • Shi SJ, Vellaichamy E, Chin SY, Smithies O, Navar LG, Pandey KN. Natriuretic peptide receptor A mediates renal sodium excretory responses to blood volume expansion. Am J Physiol Renal Physiol. 2003;285(4):F694-F702. doi: 10.1152/ajprenal.00097.2003

  • Shimizu A, Ueeda M, Watanabe H, Hina K, Yamada N, Kusachi S, Saito D, Haraoka S, Tsuji T. Enhancement of coronary conductance by alpha-human atrial natriuretic polypeptide without effects on myocardial contractility. Arzneimittelforschung. 1988;38(11):1572-1577.

  • Shirakami G, Itoh H, Suga S, Komatsu Y, Hama N, Mori K, Nakao K. Central action of C-type natriuretic peptide on vasopressin secretion in conscious rats. Neurosci Lett. 1993;159(1-2):25-28.

  • Skryabin BV, Sukonina V, Jordan U, Lewejohann L, Sachser N, Muslimov I, Tiedge H, Brosius J. Neuronal untranslated BC1 RNA: targeted gene elimination in mice. Mol Cell Biol. 2003;23(18):6435-6441.

  • Skryabin BV, Holtwick R, Fabritz L, Kruse MN, Veltrup I, Stypmann J, Kirchhof P, Sabrane K, Bubikat A, Voss M, Kuhn M. Hypervolemic hypertension in mice with systemic inactivation of the (floxed) guanylyl cyclase-A gene by alphaMHC-Cre-mediated recombination. Genesis. 2004;39(4):288-298. doi: 10.1002/gene.20056

  • Smith JB, Lincoln TM. Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor. Am J Physiol. 1987;253(1 Pt 1):147-150.

  • Soeki T, Kishimoto I, Okumura H, Tokudome T, Horio T, Mori K, Kangawa K. C-type natriuretic peptide, a novel antifibrotic and antihypertrophic agent, prevents cardiac remodeling after myocardial infarction. J Am Coll Cardiol. 2005;45(4):608-616. doi: 10.1016/j.jacc.2004.10.067

  • Sonnenberg H, Cupples WA, de Bold AJ, Veress AT. Intrarenal localization of the natriuretic effect of cardiac atrial extract. Can J Physiol Pharmacol. 1982;60(9):1149-1152.

  • Sonnenberg H, Honrath U, Chong CK, Wilson DR. Atrial natriuretic factor inhibits sodium transport in medullary collecting duct. Am J Physiol. 1986;250(6 Pt 2):F963-F966.

  • Springer J, Azer J, Hua R, Robbins C, Adamczyk A, McBoyle S, Bissell MB, Rose RA. The natriuretic peptides BNP and CNP increase heart rate and electrical conduction by stimulating ionic currents in the sinoatrial node and atrial myocardium following activation of guanylyl cyclase-linked natriuretic peptide receptors. J Mol Cell Cardiol. 2012;52(5):1122-1134. doi: 10.1016/j.yjmcc.2012.01.018

  • Steele MK, Gardner DG, Xie PL, Schultz HD. Interactions between ANP and ANG II in regulating blood pressure and sympathetic outflow. Am J Physiol. 1991;260(6 Pt 2):R1145-R1151.

  • Steinhelper ME, Cochrane KL, Field LJ. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes. Hypertension. 1990;16(3):301-307.

  • Stingo AJ, Clavell AL, Aarhus LL, Burnett JC. Cardiovascular and renal actions of C-type natriuretic peptide. Am J Physiol. 1992;262:H308-H312.

  • Stingo AJ, Clavell AL, Heublein DM, Wei CM, Pittelkow MR, Burnett JC. Presence of C-type natriuretic peptide in cultured human endothelial cells and plasma. Am J Physiol. 1992;263(4 Pt 2): H1318-H1321.

  • Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature. 1988;332(6159):78-81. doi: 10.1038/332078a0

  • Sudoh T, Minamino N, Kangawa K, Matsuo H. C-type natriuretic peptide (CNP): a new member of natriuretic peptide family identified in porcine brain. Biochem Biophys Res Commun. 1990;168(2):863-870.

  • Suematsu Y, Miura SI, Goto M, Matsuo Y, Arimura T, Kuwano T, Imaizumi S, Iwata A, Yahiro E, Saku K. LCZ696, an angiotensin receptor-neprilysin inhibitor, improves cardiac function with the attenuation of fibrosis in heart failure with reduced ejection fraction in streptozotocin-induced diabetic mice. Eur J Heart Fail. 2016. doi: 10.1002/ejhf.474.

  • Suga S, Itoh H, Komatsu Y, Ogawa Y, Hama N, Yoshimasa T, Nakao K. Cytokine-induced C-type natriuretic peptide (CNP) secretion from vascular endothelial cells—evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells. Endocrinology. 1993;133(6):3038-3041. doi: 10.1210/endo.133.6.8243333

  • Sultanian R, Deng Y, Kaufman S. Atrial natriuretic factor increases splenic microvascular pressure and fluid extravasation in the rat.
    Yüklə 192,52 Kb.

    Dostları ilə paylaş:
  • 1   2   3   4




    Verilənlər bazası müəlliflik hüququ ilə müdafiə olunur ©genderi.org 2024
    rəhbərliyinə müraciət

        Ana səhifə